NCT01966991View on ClinicalTrials.gov

Prenatal Screening for Down Syndrome With DNAFirst

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

December 31, 2015

Conditions
Trisomy 21Trisomy 18Trisomy 13Monosomy X
Trial Locations (1)

02905

Women & Infants Hospital of Rhode Island, Providence

Sponsors

Collaborators (1)

Natera, Inc.
All Listed Sponsors
collaborator

Natera, Inc.

INDUSTRY

lead

Women and Infants Hospital of Rhode Island

OTHER

NCT01966991 - Prenatal Screening for Down Syndrome With DNAFirst | Biotech Hunter | Biotech Hunter